We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs. United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF). The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option. You are a driven pharmaceutical sales professional who thrives in complex specialty markets and is motivated by the opportunity to make a meaningful impact for patients living with rare and serious diseases. You bring strong clinical acumen, the ability to confidently communicate sophisticated scientific data, and a proven track record of building trusted relationships with pulmonologists and other key healthcare providers. You enjoy owning your territory like a business—strategically navigating challenging accounts, identifying opportunities, and delivering results. Most importantly, you’re energized by the chance to be part of an exciting moment of growth at United Therapeutics, helping expand awareness and access to therapies like Tyvaso for patients living with conditions such as PH-ILD and IPF. The Advanced Lung Disease (ALD) Specialist maintains and increases sales of all UT products, with a primary focus on Tyvaso, assigned within a defined territory of targeted physicians and key accounts through effective territory management and execution of sales/marketing strategies. Serves as an important educational resource for all physicians and other healthcare professionals (HCP's) involved in the treatment of PH-ILD and/or IPF.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level